DRIO

DarioHealth Corp. (NASDAQ:DRIO) is a digital therapeutics company that has undergone significant transformation since its founding. Originally incorporated in 2011 as LabStyle Innovations Corp., the company changed its name to DarioHealth Corp. in July 2016 and went public the same year. Based in New York, DarioHealth has evolved from a direct-to-consumer diabetes management company into a comprehensive digital health platform serving multiple chronic conditions through business-to-business partnerships with employers, health plans, and pharmaceutical companies across the United States, Canada, European Union, Australia, and New Zealand.